We are live on ! Find out more
CERE

Cerevel Therapeutics Holdings, Inc. Common Stock
CERE

Delisted

CERE was delisted on the 31st of July, 2024.

Back to rankings

195 hedge funds and large institutions have $6.64B invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 91 funds opening new positions, 61 increasing their positions, 33 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

507% more first-time investments, than exits

New positions opened: 91 | Existing positions closed: 15

175% more funds holding in top 10

Funds holding in top 10: 4 → 11 (+7)

116% more capital invested

Capital invested by funds: $3.07B → $6.64B (+$3.57B)

85% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 33

64% more funds holding

Funds holding: 119 → 195 (+76)

3% more call options, than puts

Call options by funds: $79.6M | Put options by funds: $77.1M

Holders
195
Holders Change
+76
Holders Change %
+63.87%
% of All Funds
2.84%
Holding in Top 10
11
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+175%
% of All Funds
0.16%
New
91
Increased
61
Reduced
33
Closed
15
Calls
$79.6M
Puts
$77.1M
Net Calls
+$2.49M
Net Calls Change
+$1.82M

Top Buyers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
+$190M
2
BCI
Bain Capital Investors
Massachusetts
+$157M
3
Fidelity International
Fidelity International
Bermuda
+$79.5M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$54.9M
5
UOC
UBS O'Connor
Illinois
+$49.6M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$400M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$137M
3
AG
Artal Group
Luxembourg
-$46.9M
4
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$39.8M
5
Millennium Management
Millennium Management
New York
-$29.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Group One Trading
126
Group One Trading
Illinois
$852K +$577K +20,085 New
ASRS
127
Arizona State Retirement System
Arizona
$840K +$56.1K +1,954 +11%
Two Sigma Investments
128
Two Sigma Investments
New York
$835K -$124K -4,300 -18%
AQR Capital Management
129
AQR Capital Management
Connecticut
$830K +$563K +19,578 New
ProShare Advisors
130
ProShare Advisors
Maryland
$810K +$549K +19,097 New
State Board of Administration of Florida Retirement System
131
State Board of Administration of Florida Retirement System
Florida
$770K +$14.4K +500 +3%
Handelsbanken Fonder
132
Handelsbanken Fonder
Sweden
$687K +$132K +4,600 +40%
Teacher Retirement System of Texas
133
Teacher Retirement System of Texas
Texas
$680K -$51.3K -1,786 -10%
DC
134
Diametric Capital
Massachusetts
$671K +$455K +15,826 New
Wolverine Trading
135
Wolverine Trading
Illinois
$669K +$453K +15,770 New
YCM
136
Yakira Capital Management
Connecticut
$636K +$431K +15,000 New
Blackstone Inc
137
Blackstone Inc
New York
$617K +$418K +14,545 New
GCP
138
GSA Capital Partners
United Kingdom
$577K +$391K +13,607 New
CCM
139
Chicago Capital Management
Illinois
$572K +$388K +13,500 New
Zurich Cantonal Bank
140
Zurich Cantonal Bank
Switzerland
$558K +$31.3K +1,091 +9%
PCM
141
PenderFund Capital Management
British Columbia, Canada
$528K +$270K +9,400 New
Victory Capital Management
142
Victory Capital Management
Texas
$492K +$333K +11,592 New
Public Employees Retirement Association of Colorado
143
Public Employees Retirement Association of Colorado
Colorado
$464K -$9.17K -319 -3%
CCM
144
Cinctive Capital Management
New York
$460K +$312K +10,844 New
AB
145
Amalgamated Bank
New York
$425K +$23.2K +809 +9%
MCM
146
Moore Capital Management
New York
$424K +$287K +10,000 New
SO
147
STRS Ohio
Ohio
$415K -$11.5K -400 -4%
Pictet Asset Management
148
Pictet Asset Management
Switzerland
$405K +$275K +9,563 New
GAM
149
Gotham Asset Management
New York
$398K +$270K +9,394 New
AIM
150
Aigen Investment Management
New York
$348K +$236K +8,215 New
4 5
6
7 8

CERE Hedge Fund Activity: Q4 2023 in Review

195 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) for Q4 2023, worth a combined $6.64B — up 116% from $3.07B a quarter earlier.

Buyers outnumbered sellers: 91 funds opened new CERE positions and 15 closed out — a net gain of 76 holders — while 61 added to existing stakes and 33 trimmed.

The largest buyer was Avoro Capital Advisors, adding an estimated $190M. The largest seller was Fidelity Investments, cutting an estimated $400M.

  • 195 institutional investors held Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) as of Q4 2023, up from 119 in Q3 2023.
  • Funds reported $6.64B of Cerevel Therapeutics Holdings, Inc. Common Stock stock for Q4 2023, up 116% quarter-over-quarter.
  • 91 funds opened new Cerevel Therapeutics Holdings, Inc. Common Stock positions in Q4 2023 and 15 closed out, a net change of +76 holders.
  • The largest Cerevel Therapeutics Holdings, Inc. Common Stock buyer in Q4 2023 was Avoro Capital Advisors, an estimated $190M added.
  • The largest Cerevel Therapeutics Holdings, Inc. Common Stock seller in Q4 2023 was Fidelity Investments, an estimated $400M sold.

Based on aggregated 13F filings for Q4 2023.